(34 days)
Not Found
No
The summary describes a device that uses sensors and software to analyze physiological signals (PAT, oximetry, actigraphy) to derive indices and sleep staging. There is no mention of AI, ML, or related concepts in the description of the device's technology or performance studies. The analysis appears to be based on established signal processing techniques rather than AI/ML algorithms.
No.
The device is described as a "diagnostic aid" for detecting sleep-related breathing disorders and sleep staging, not for providing treatment.
Yes
The "Intended Use / Indications for Use" section explicitly states, "The WP200S-2 is a diagnostic aid for the detection of sleep related breathing disorders and sleep staging..." and the "Device Description" section reiterates, "The WP200S-2 is a diagnostic aid for the detection of sleep related breathing disorders..."
No
The device description explicitly lists multiple hardware components including a finger PAT probe, an embedded pulse oximeter, an embedded actigraph, electronics, and a power supply, in addition to the device software.
Based on the provided information, the Watch-PAT200S-2 (WP200S-2) device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- WP200S-2 Function: The WP200S-2 is a non-invasive device that measures physiological signals directly from the patient's body (finger and wrist) using technologies like Peripheral Arterial Tonometry (PAT), pulse oximetry, and actigraphy. It does not analyze samples taken from the body.
Therefore, the WP200S-2 falls under the category of a non-invasive diagnostic device rather than an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The Watch-PAT200S-2 (WP200S-2) device is a non-invasive home care device for use with patients suspected to have sleep related breathing disorders. The WP200S-2 is a diagnostic aid for the detection of sleep related breathing disorders and sleep staging (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake). The WP200S-2 generates a peripheral arterial tonometry ("PAT") Respiratory Disturbance Index ("PRDI"), Apnea-Hypopnea index ("PAHI") and PAT sleep staging identification (PSTAGES). The WP200S-2's PSTAGES provides supplemental information to its PRDI/PAHI. The WP200S-2's PSTAGES is not intended to be used as the sole or primary basis for diagnosing any sleep related breathing disorder, prescribing treatment, or determining whether additional diagnostic assessment is warranted.
The WP200S-2 is not indicated for children less than 17 years old.
Product codes (comma separated list FDA assigned to the subject device)
MNR
Device Description
The WATCH-Pat200-2 System (WP200S-2) is a non-invasive home care device for use with patients suspected to having sleep related breathing disorders. The WP200S-2 is a diagnostic aid for the detection of sleep related breathing disorders [Respiratory disturbance index (RDI), apnea - hypopnea index (AHI)] and sleep staging (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake) based on Peripheral Arterial Tonometry (PAT); a non-invasive technology. a, based on Peripheral Arterial Tonometry (PAT); a non-invasive technology.
The WP200S-2 System is a compact version of the WP100S-2 System, both consist of: (1) a finger PAT probe, which is used to detect the PAT signal; (2) an embedded pulse oximeter using a second probe that is attached to another finger for measuring blood oxygen saturation; (3) an embedded actigraph which is used to determine periods of sleep based on the motion of the wrist; (4) Electronics which include a controller that records the information supplied by the PAT finger probe, oximeter, and actigraph; (5) the device software; and (6) a power supply.
The device is worn on the wrist, and continuously measures the relative state of the vasomotor activity in the distal part of the finger, by a finger-mounted probe based on a plethysmographic method. The measured signal is acquired from a self contained, optopneumatic sensor.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Distal part of the finger, wrist
Indicated Patient Age Range
17 years or older
Intended User / Care Setting
Home care, patients suspected to have sleep related breathing disorders
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The WP200S-2 System is substantially equivalent in all aspects, including technological characteristics, mode of operation, performance characteristics, intended use, etc., to the commercially available WP100S-2 System, cleared under K080427 and in respect of its hardware is also substantially equivalent to the WP200i System cleared under K081037.
The principle changes between the WP100S-2 and the WP200S-2 systems include minor hardware modifications that were made to the controller components to enable more compact design and lower power consumption. The hardware of the WP200S-2 system is identical to the hardware of the WP200i, both are compact versions of the Watch Pat system. This WP200i/WP200S-2 hardware was subjected to the following testing (K081037):
- Electrical and electromagnetic testing
- Electronics design verification test
- Performance testing demonstrating the accuracy of the captured signals and device's reproducibility
The software of the WP200S-2 is the same software as the WP100S-2, allowing for the detection of sleep related breathing disorders and presentation of both the PRDI and PAHI indices and PAT sleep staging identification; PSTAGES (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake). A comprehensive software verification and validation activities were conducted to ensure that the software meets all software requirement specifications.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.2375 Breathing frequency monitor.
(a)
Identification. A breathing (ventilatory) frequency monitor is a device intended to measure or monitor a patient's respiratory rate. The device may provide an audible or visible alarm when the respiratory rate, averaged over time, is outside operator settable alarm limits. This device does not include the apnea monitor classified in § 868.2377.(b)
Classification. Class II (performance standards).
0
1081982
Itamar Medical Ltd Watch PAT200S-2 System
AUG 1 4 2008
| Applicant's Name: | |
|---|---|
| Itamar Medical Itd. | |
| 2 Ha'eshel st. | |
| Caesarea 38900, Israel | |
| Tel: +972 4 617 7000 | |
| Fax: +972 4 627 5598 | |
| Contact Person: | |
| Jonathan Kahan, Esq. | |
| Hogan & Hartson, L.L.P. | |
| Columbia Square | |
| 555 Thirteenth Street, NW | |
| Washington, DC 20004-1109 | |
| Tel: (202)637-5794 | |
| Fax: (202)637-5910 | |
| and | |
| Dorit Winitz, Ph. D | |
| Biomedical Strategy (2004) Ltd. | |
| Moshe Aviv Tower, 34th Floor, | |
| 7 Jabotinsky Street | |
| Ramat Gan 52520, Israel | |
| Tel: +972-3-612-3281 | |
| Fax: +972-3-612-3282 | |
| dorit@ebms.co.il | |
| Date Prepared: | July 11, 2008 |
| Trade Name: | Watch-PAT 200S-2 ("WP200S-2") |
| Common Name: | Ventilatory Effort Recorder |
:
1
21 CFR 868.2375 Class:II MNR (Ventilatory Effort Recorder).
Classification Name: Breathing Frequency Monitor
Medical Specialty: Anesthesiology
Predicate Devices:
- " Watch-Pat100S-2 ("WP100S-2") (Itamar Ltd), cleared under K080427; product code MNR (ventilatory effort recorder).
- Watch-Pat200i ("WP200i") (Itamar Ltd), cleared under K081037; product code . MNR (ventilatory effort recorder).
Device Description:
The WATCH-Pat200-2 System (WP200S-2) is a non-invasive home care device for use with patients suspected to having sleep related breathing disorders. The WP200S-2 is a diagnostic aid for the detection of sleep related breathing disorders [Respiratory disturbance index (RDI), apnea - hypopnea index (AHI)] and sleep staging (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake) based on Peripheral Arterial Tonometry (PAT); a non-invasive technology. a, based on Peripheral Arterial Tonometry (PAT); a non-invasive technology.
The WP200S-2 System is a compact version of the WP100S-2 System, both consist of: (1) a finger PAT probe, which is used to detect the PAT signal; (2) an embedded pulse oximeter using a second probe that is attached to another finger for measuring blood oxygen saturation; (3) an embedded actigraph which is used to determine periods of sleep based on the motion of the wrist; (4) Electronics which include a controller that records the information supplied by the PAT finger probe, oximeter, and actigraph; (5) the device software; and (6) a power supply.
The device is worn on the wrist, and continuously measures the relative state of the vasomotor activity in the distal part of the finger, by a finger-mounted probe based on a plethysmographic method. The measured signal is acquired from a self contained, optopneumatic sensor.
Intended Use:
The Watch-PAT200S-2 (WP200S-2) device is a non-invasive home care device for use with patients suspected to have sleep related breathing disorders. The WP200S-2 is a diagnostic aid for the detection of sleep related breathing disorders and sleep staging (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake). The WP200S-2 generates a peripheral arterial tonometry ("PAT") Respiratory Disturbance Index ("PRDI"), Apnea-Hypopnea index ("PAHI") and PAT sleep staging identification (PSTAGES). The WP100S-2's PSTAGES provides supplemental information to its PRDI/PAHI. The WP100S-2's PSTAGES is not intended to be used as the sole or
2
primary basis for diagnosing any sleep related breathing disorder, prescribing treatment, or determining whether additional diagnostic assessment is warranted.
The WP100S-2 is not indicated for children less than 17 years old.
Performance Data & Substantial Equivalence:
The WP200S-2 System is substantially equivalent in all aspects, including technological characteristics, mode of operation, performance characteristics, intended use, etc., to the commercially available WP100S-2 System, cleared under K080427 and in respect of its hardware is also substantially equivalent to the WP200i System cleared under K081037.
The principle changes between the WP100S-2 and the WP200S-2 systems include minor hardware modifications that were made to the controller components to enable more compact design and lower power consumption. The hardware of the WP200S-2 system is identical to the hardware of the WP200i, both are compact versions of the Watch Pat system. This WP200i/WP200S-2 hardware was subjected to the following testing (K081037):
- Electrical and electromagnetic testing 로
- 해 Electronics design verification test
- 보 Performance testing demonstrating the accuracy of the captured signals and device's reproducibility
The software of the WP200S-2 is the same software as the WP100S-2, allowing for the detection of sleep related breathing disorders and presentation of both the PRDI and PAHI indices and PAT sleep staging identification; PSTAGES (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake). A comprehensive software verification and validation activities were conducted to ensure that the software meets all software requirement specifications.
Based on the design verification and validation processes, performed as a result of risk analysis assessment, Itamar Medical Ltd. believes that the WP200S-2 System is substantially equivalent to the cleared WP100S-2 System without raising new safety and/or effectiveness issues.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like symbol with three curved lines forming its body and wings. The logo is surrounded by text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES (USA)" in a circular arrangement. The text is in all caps and is evenly spaced around the logo.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Itamar Medical Limited C/O Mr. Jonathan S. Kahan Regulatory Counsel Hogan & Hartson L.L.P 555 Thirtcenth Street, NW Washington, DC 20004
AUG 1 4 2008
Re: K081982
Trade/Device Name: Watch-PAT200S-2 (WP200S-2) Regulation Number: 21 CFR 868.2375 Regulation Name: Breathing Frequency Monitor Regulatory Class: II Product Code: MNR Dated: July 11, 2008 Received: July 11, 2008
Dear Mr. Kahan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Mr. Kahan
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
Th. Schmuls-Pend, m.D.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use Statement
510(k) Number (if known):
Device Name:
Indications for Use:
The Watch-PAT200S-2 (WP200S-2) device is a non-invasive home care device for use with patients suspected to have sleep related breathing disorders. The WP200S-2 is a diagnostic aid for the detection of sleep related breathing disorders and sleep staging (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake). The WP200S-2 generates a peripheral arterial tonometry ("PAT") Respiratory Disturbance Index ("PRDI"), Apnea-Hypopnea index ("PAHI") and PAT sleep staging identification (PSTAGES). The WP200S-2's PSTAGES provides supplemental information to its PRDI/PAHI. The WP200S-2's PSTAGES is not intended to be used as the sole or primary basis for diagnosing any sleep related breathing disorder, prescribing treatment, or determining whether additional diagnostic assessment is warranted.
The WP200S-2 is not indicated for children less than 17 years old.
M. Thel
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number:________________________________________________________________________________________________________________________________________________________________
Prescription Use X (Per 21 C.F.R. 801.109) AND/OR
Over-The-Counter Use (Per 21 C.F.R. 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)